Value of (the percentage of) target grip strength for which grip hold duration is being measured in the grip strength fatigue trial being recorded
Registration Status:
Qualified
Permissible Values:
Data Type:
Value List
Unit of Measure:
Ids:
Value
Code Name
Code
Code System
Code Description
100% of Target
100% of Target
100 percent of Target
90% of Target
90% of Target
90 percent of Target
80% of Target
80% of Target
80 percent of Target
70% of Target
70% of Target
70 percent of Target
60% of Target
60% of Target
60 percent of Target
Designations:
Designation:
Grip strength fatigue percent target value
Tags:
Designations:
Definition:
Value of (the percentage of) target grip strength for which grip hold duration is being measured in the grip strength fatigue trial being recorded
Tags:
Reference Documents:
ID:
Title:
URI:
Provider Org:
Language Code:
Document:
Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, Watson ML, Mahoney K, Chen M, Saikali K, Mao J, Russell AJ, Hansen RL, Malik F, Wolff AA; Neals/Cytokinetics Study Team. Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13(5):430–438.
ID:
Title:
URI:
Provider Org:
Language Code:
Document:
Shefner J, Cudkowicz ME, Maragakis N, Cedarbaum JM, Lee J, Jones D, Watson ML, Shaver K, Chen M, Saikali K, Mao J, Russell AK, Hansen L, Malik F, Wolff AA, for the NEALS/Cytokinetics Study Team. Safety, tolerability and pharmacodynamics of a skeletal muscle activator in Amyotrophic Lateral Sclerosis. (submitted for publication)